Brookstone Capital Management Decreases Position in The Clorox Company (NYSE:CLX)

Brookstone Capital Management lessened its position in The Clorox Company (NYSE:CLX) by 91.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 7,484 shares of the company’s stock after selling 83,052 shares during the period. Brookstone Capital Management’s holdings in Clorox were worth $1,146,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in CLX. Federated Hermes Inc. raised its stake in shares of Clorox by 16.4% in the third quarter. Federated Hermes Inc. now owns 4,744 shares of the company’s stock worth $622,000 after purchasing an additional 670 shares during the last quarter. Mutual Advisors LLC lifted its stake in Clorox by 23.2% during the 3rd quarter. Mutual Advisors LLC now owns 3,803 shares of the company’s stock valued at $498,000 after acquiring an additional 717 shares during the period. Tower Research Capital LLC TRC boosted its holdings in shares of Clorox by 93.5% during the 3rd quarter. Tower Research Capital LLC TRC now owns 13,793 shares of the company’s stock valued at $1,808,000 after acquiring an additional 6,663 shares during the last quarter. Bank of Nova Scotia grew its stake in shares of Clorox by 237.7% in the third quarter. Bank of Nova Scotia now owns 36,232 shares of the company’s stock worth $4,749,000 after acquiring an additional 25,502 shares during the period. Finally, Gotham Asset Management LLC raised its holdings in shares of Clorox by 78.1% during the third quarter. Gotham Asset Management LLC now owns 35,939 shares of the company’s stock valued at $4,710,000 after purchasing an additional 15,759 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 0.1 %

NYSE CLX opened at $136.47 on Friday. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.14. The stock’s 50 day moving average is $136.95 and its 200 day moving average is $143.80. The stock has a market cap of $16.95 billion, a PE ratio of 70.71, a P/E/G ratio of 2.19 and a beta of 0.39.

Clorox (NYSE:CLX) last released its earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, topping the consensus estimate of $1.33 by $0.38. The firm had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The company’s quarterly revenue was down 5.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.51 earnings per share. Research analysts predict that The Clorox Company will post 5.91 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on CLX shares. Evercore ISI cut their target price on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research report on Wednesday, May 1st. Citigroup cut their price objective on Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Argus raised Clorox to a “hold” rating in a report on Tuesday, June 4th. UBS Group cut their price target on Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research note on Wednesday, April 17th. Five investment analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company’s stock. According to data from MarketBeat.com, Clorox has an average rating of “Hold” and a consensus target price of $145.33.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.